Tower Research Capital LLC (TRC) - ELOXX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,802
-8.7%
1,830
-26.2%
0.00%
Q2 2023$9,643
+137657.1%
2,479
+2.6%
0.00%
Q1 2023$70.0%2,417
-36.2%
0.00%
Q4 2022$73,7890.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 54,075$260,1010.08%
AMERICAN FINANCIAL GROUP INC 37,000$1780.06%
ARMISTICE CAPITAL, LLC 275,000$1,322,7500.02%
Atom Investors LP 10,638$51,1690.01%
Altshuler Shaham Ltd 25,123$120,8420.00%
MENORA MIVTACHIM HOLDINGS LTD. 52,355$251,8280.00%
Clal Insurance Enterprises Holdings Ltd 13,526$650.00%
WELLS FARGO & COMPANY/MN 1,172$5,6370.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 19,588$93,2640.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders